During the past decade, Institut Salah Azaiz conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Salah Azaiz" #1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institut Salah Azaiz" are "Diabetes" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Institut Salah Azaiz" in a lesser frequency.

Most popular intervention types in "Institut Salah Azaiz" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide 750 mg/m^2" (1 trials), "Doxorubicin 50 mg/m^2" (1 trials), "Prednisone 100 mg/m^2" (1 trials), "Rituximab 375 mg/m^2" (1 trials) and "VELCADE 1.3 mg/m^2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Salah Azaiz" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institut Salah Azaiz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institut Salah Azaiz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Salah Azaiz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".